Fennec Announces Incremental $5 Million Investment from Petrichor
~ Supports Strategic Discussions and Global Launch Activities ~
~ Extends Access to Additional Undrawn Capital As Needed During Global PEDMARK® Rollout ~
Related news for (FENC)
- Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
- Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
- Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany
- Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
- Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management